Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma.
Tetsuya TachiiriKiyoyuki MinamiguchiRyosuke TaijiTakeshi SatoShohei ToyodaTakeshi MatsumotoYuto ChanokiHideki KunichikaSatoshi YamauchiSho ShimizuHideyuki NishiofukuNagaaki MarugamiYuki TsujiTadashi NamisakiHitoshi YoshijiToshihiro TanakaPublished in: Cancers (2024)
The short-term LEN-TACE is feasible and safe, demonstrating promising outcomes with a high CR ratio, contributing to lipiodol retention in the tumor after cTACE, and extended PFS. To confirm the advantages of this treatment protocol, a prospective clinical trial is mandatory.